Myomo (MYO) EBT Margin Growth (3y) (2019 - 2025)
Myomo (MYO) EBT Margin Growth (3y) (2019 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.38 Bn | 176.08 Bn | 6.27 Bn | -305.00 |
| 2 | Stryker | 129.56 Bn | 126.68 Bn | 3.81 Bn | -9.00 |
| 3 | Medtronic | 109.00 Bn | 99.78 Bn | 6.41 Bn | 55.00 |
| 4 | Boston Scientific | 68.59 Bn | 67.13 Bn | 3.61 Bn | 923.00 |
| 5 | Edwards Lifesciences | 47.58 Bn | 43.90 Bn | 1.29 Bn | -480.00 |
| 6 | Dexcom | 28.65 Bn | 27.53 Bn | 750.30 Mn | 1,391.00 |
| 7 | GE HealthCare Technologies | 28.55 Bn | 26.27 Bn | 1.98 Bn | -176.00 |
| 8 | Smith & Nephew | 27.05 Bn | 26.48 Bn | - | - |
| 9 | Koninklijke Philips | 25.59 Bn | 22.46 Bn | 2.07 Bn | 2,114.00 |
| 10 | Myomo | 43.43 Mn | 24.46 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 3,577.00 |
| Jun 30, 2025 | 3,282.00 |
| Mar 31, 2025 | 3,695.00 |
| Dec 31, 2024 | 12,234.00 |
| Sep 30, 2024 | 3,683.00 |
| Jun 30, 2024 | 7,054.00 |
| Mar 31, 2024 | 2,554.00 |
| Dec 31, 2023 | -535.00 |
| Sep 30, 2023 | 10,502.00 |
| Jun 30, 2023 | 36,562.00 |
| Mar 31, 2023 | 30,158.00 |
| Dec 31, 2022 | 38,468.00 |
| Sep 30, 2022 | 38,890.00 |
| Jun 30, 2022 | 21,212.00 |
| Mar 31, 2022 | 24,219.00 |
| Dec 31, 2021 | 25,789.00 |
| Sep 30, 2021 | 39,834.00 |
| Jun 30, 2021 | 34,019.00 |
| Mar 31, 2021 | 64,175.00 |
| Dec 31, 2020 | 29,016.00 |